News Briefs: Invacare Update; Patent Trolls; VC Trends
This article was originally published in The Gray Sheet
Invacare reports its earnings are hindered by an FDA consent decree, but management hopes to be released from the agreement soon. The American Hospital Association signs onto a letter to Congress calling for a crackdown on so-called “patent trolls.” More news in brief
You may also be interested in...
Patent attorneys suggest lawsuits from firms that buy up device patents purely to pursue litigation, which appears to have occurred recently with Medtronic’s kyphoplasty patents, may become a more common occurrence.
Obama signs appropriations bill giving FDA expanded user fee access. Bausch & Lomb IPO. More news.
Zimmer is investigating failures of its Durom hip implants after a prominent joint reconstruction surgeon sent a letter reporting a series of problems with the device to the American Association of Hip and Knee Surgeons